Led by Legend Capital, GS Biotech Completes Nearly CNY100 million Pre-A Round Financing
HONG KONG, Dec 9, 2022 - (ACN Newswire) - Recently, Zhongke Guosheng (Hangzhou) Technology Co., Ltd (hereinafter referred to as "GS Biotech") officially announced the completion of its nearly CNY100 million pre-A round financing, led by Legend Capital.
- HONG KONG, Dec 9, 2022 - (ACN Newswire) - Recently, Zhongke Guosheng (Hangzhou) Technology Co., Ltd (hereinafter referred to as "GS Biotech") officially announced the completion of its nearly CNY100 million pre-A round financing, led by Legend Capital.
- Founded in 2021 with the vision of "Biomass Change Lives", GS Biotech is a bio-based material and R&D company dedicated to building a bio-based material industry chain.
- GS Biotech has pioneered the HMF continuous production process globally and realized the large-scale and low-cost production of HMF.
- The core team of GS Biotech graduated from the Dalian Institute of Chemical Physics of the Chinese Academy of Sciences.